Vicky Pui‐Chi Tin

982 total citations
11 papers, 787 citations indexed

About

Vicky Pui‐Chi Tin is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Vicky Pui‐Chi Tin has authored 11 papers receiving a total of 787 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Oncology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Vicky Pui‐Chi Tin's work include Lung Cancer Treatments and Mutations (5 papers), RNA modifications and cancer (4 papers) and Cancer therapeutics and mechanisms (2 papers). Vicky Pui‐Chi Tin is often cited by papers focused on Lung Cancer Treatments and Mutations (5 papers), RNA modifications and cancer (4 papers) and Cancer therapeutics and mechanisms (2 papers). Vicky Pui‐Chi Tin collaborates with scholars based in Hong Kong, China and United States. Vicky Pui‐Chi Tin's co-authors include Maria Pik Wong, Alan Dart‐Loon Sihoe, Elaine Lai‐Han Leung, Yupo Ma, Louis M. Fink, Ronald R. Fiscus, James W. Tung, Lik Cheung Cheng, Lik‐Cheung Cheng and Zhijie Xiao and has published in prestigious journals such as PLoS ONE, Cancer and Antioxidants and Redox Signaling.

In The Last Decade

Vicky Pui‐Chi Tin

11 papers receiving 774 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vicky Pui‐Chi Tin Hong Kong 9 479 459 220 219 81 11 787
Suneetha B. Thomas United States 12 522 1.1× 628 1.4× 242 1.1× 256 1.2× 95 1.2× 17 1.0k
Igor Bado United States 13 388 0.8× 331 0.7× 119 0.5× 184 0.8× 67 0.8× 16 690
Cuiju Tang China 14 340 0.7× 382 0.8× 240 1.1× 178 0.8× 99 1.2× 47 853
Yeonjoo Jung South Korea 18 241 0.5× 689 1.5× 156 0.7× 182 0.8× 76 0.9× 26 953
Shogo Okazaki Japan 15 257 0.5× 451 1.0× 167 0.8× 244 1.1× 73 0.9× 29 752
Ángel Guerrero‐Zotano Spain 12 454 0.9× 735 1.6× 188 0.9× 445 2.0× 44 0.5× 29 1.1k
Sanghyun Lee South Korea 5 439 0.9× 610 1.3× 92 0.4× 266 1.2× 53 0.7× 6 923
Nayoung Jun South Korea 4 440 0.9× 607 1.3× 92 0.4× 267 1.2× 53 0.7× 7 919
Nicolaos Palaskas United States 8 266 0.6× 625 1.4× 316 1.4× 290 1.3× 74 0.9× 10 898
Alessandro Perez Italy 15 272 0.6× 301 0.7× 206 0.9× 181 0.8× 41 0.5× 41 693

Countries citing papers authored by Vicky Pui‐Chi Tin

Since Specialization
Citations

This map shows the geographic impact of Vicky Pui‐Chi Tin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vicky Pui‐Chi Tin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vicky Pui‐Chi Tin more than expected).

Fields of papers citing papers by Vicky Pui‐Chi Tin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vicky Pui‐Chi Tin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vicky Pui‐Chi Tin. The network helps show where Vicky Pui‐Chi Tin may publish in the future.

Co-authorship network of co-authors of Vicky Pui‐Chi Tin

This figure shows the co-authorship network connecting the top 25 collaborators of Vicky Pui‐Chi Tin. A scholar is included among the top collaborators of Vicky Pui‐Chi Tin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vicky Pui‐Chi Tin. Vicky Pui‐Chi Tin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Xiao, Zhijie, Siqi Wang, Yun Li, et al.. (2024). The Dual Role of the NFATc2/galectin‐9 Axis in Modulating Tumor‐Initiating Cell Phenotypes and Immune Suppression in Lung Adenocarcinoma. Advanced Science. 11(20). e2306059–e2306059. 6 indexed citations
2.
Wang, Siqi, Jing Liu, Jing Qin, et al.. (2020). CAMK2A supported tumor initiating cells of lung adenocarcinoma by upregulating SOX2 through EZH2 phosphorylation. Cell Death and Disease. 11(6). 410–410. 17 indexed citations
3.
Liu, Jing, Jing Qin, Yun Zhu, et al.. (2019). CAMK2A Supported Tumor Initiating Cells of Lung Adenocarcinoma by Upregulating SOX2 Through EZH2 Phosphorylation. SSRN Electronic Journal. 1 indexed citations
4.
Xiao, Zhijie, Jing Liu, Yun Zhu, et al.. (2017). NFATc2 enhances tumor-initiating phenotypes through the NFATc2/SOX2/ALDH axis in lung adenocarcinoma. eLife. 6. 44 indexed citations
5.
Leung, Elaine Lai‐Han, Xing‐Xing Fan, Maria Pik Wong, et al.. (2015). Targeting Tyrosine Kinase Inhibitor-Resistant Non-Small Cell Lung Cancer by Inducing Epidermal Growth Factor Receptor Degradation via Methionine 790 Oxidation. Antioxidants and Redox Signaling. 24(5). 263–279. 69 indexed citations
6.
Figueiredo-Pontes, Lorena Lôbo de, Vicky Pui‐Chi Tin, Lap‐Ping Chung, et al.. (2014). Identification and Characterization of ALK Kinase Splicing Isoforms in Non–Small-Cell Lung Cancer. Journal of Thoracic Oncology. 9(2). 248–253. 14 indexed citations
7.
Liu, Jing, Zhijie Xiao, Vicky Pui‐Chi Tin, et al.. (2013). Lung cancer tumorigenicity and drug resistance are maintained through ALDHhiCD44hi tumor initiating cells. Oncotarget. 4(10). 1698–1711. 82 indexed citations
8.
Leung, Elaine Lai‐Han, Vicky Pui‐Chi Tin, Alan Dart‐Loon Sihoe, et al.. (2011). A novel KIF5B‐ALK variant in nonsmall cell lung cancer. Cancer. 117(12). 2709–2718. 74 indexed citations
9.
Leung, Elaine Lai‐Han, Ronald R. Fiscus, James W. Tung, et al.. (2010). Non-Small Cell Lung Cancer Cells Expressing CD44 Are Enriched for Stem Cell-Like Properties. PLoS ONE. 5(11). e14062–e14062. 376 indexed citations
10.
Tam, Issan Yee San, Vicky Pui‐Chi Tin, Daniel Chua, et al.. (2009). Double EGFR mutants containing rare EGFR mutant types show reduced in vitro response to gefitinib compared with common activating missense mutations. Molecular Cancer Therapeutics. 8(8). 2142–2151. 64 indexed citations
11.
Tam, Issan Yee San, Vicky Pui‐Chi Tin, Daniel Chua, et al.. (2009). Src Promotes Survival and Invasion of Lung Cancers with Epidermal Growth Factor Receptor Abnormalities and Is a Potential Candidate for Molecular-Targeted Therapy. Molecular Cancer Research. 7(6). 923–932. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026